Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Antitumor agent MSC-1936369B shows safety in phase I trial

June 9, 2010

Irinotecan/S-1 active in 5-FU-resistant bladder cancer cell lines

June 9, 2010

Phase III trial of plitidepsin initiated in multiple myeloma

June 8, 2010

TK therapy R&D project receives grant from Regione Lombardia

June 8, 2010

Scancell and ImmuneRegen BioSciences form strategic alliance

June 8, 2010

Ascenta and sanofi-aventis sign license agreement in oncology

June 8, 2010

Phase I trial data presented on GSK-923295 in solid tumors

June 8, 2010

Lilly claims new hedgehog signaling inhibitors

June 8, 2010

CT-322 is active in phase II trial in recurrent glioblastoma

June 7, 2010

FDA grants orphan drug status to telatinib for gastric cancer

June 7, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...